Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome

Seminars in Reproductive Medicine

Volumn 31, Issue 5, 2013, Pages 365-369

  Wang, Shunping ^a   Alvero, Ruben ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

ethnic racial difference; polycystic ovary syndrome; prevalence

Indexed keywords

CLOMIFENE CITRATE; ESTROGEN; GESTAGEN; METFORMIN; SPIRONOLACTONE;

ACNE; AFRICAN AMERICAN; ALOPECIA; ARTICLE; CAUCASIAN; CHINESE; ETHNIC DIFFERENCE; ETHNICITY; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; HIRSUTISM; HISPANIC; HUMAN; INDIAN; JAPANESE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; RACE DIFFERENCE;

AFRICAN AMERICANS; ASIAN AMERICANS; CONGRESSES AS TOPIC; EVIDENCE-BASED MEDICINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; METABOLIC SYNDROME X; NATIONAL INSTITUTES OF HEALTH (U.S.); POLYCYSTIC OVARY SYNDROME; PREVALENCE; UNITED STATES;

EID: 84881484665     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0033-1348895     Document Type: Article

References (34)

1. Neel J. V. Diabetes mellitus: a "thriftyo" genotype rendered detrimental by "progresso"? Am J Hum Genet: 1962; 14 353 362
2. National Institutes of Health Evidence-based Methodology Workshop on Polycystic Ovarian Syndrome (PCOS). Available from: http://www.nichd.nih.gov/ about/meetings/2012/Pages/120512.aspx
3. Stein I., Leventhal M. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol: 1935; 29 181
4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril: 2004; 81 1 19 25
5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod: 2004; 19 1 41 47
6. Azziz R., Carmina E., Dewailly D., et al. Androgen Excess Society Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab: 2006; 91 11 4237 4245 (Pubitemid 44833391)
7. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev: 1997; 18 6 774 800 (Pubitemid 28009567)
8. Moran L. J., Misso M. L., Wild R. A., Norman R. J. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update: 2010; 16 4 347 363
9. Park Y. W., Zhu S., Palaniappan L., Heshka S., Carnethon M. R., Heymsfield S. B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med: 2003; 163 4 427 436 (Pubitemid 36241019)
10. Solomon C. G., Hu F. B., Dunaif A., et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA: 2001; 286 19 2421 2426 (Pubitemid 33098160)
11. Boomsma C. M., Eijkemans M. J., Hughes E. G., Visser G. H., Fauser B. C., Macklon N. S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update: 2006; 12 6 673 683 (Pubitemid 44605508)
12. Legro R. S., Chiu P., Kunselman A. R., Bentley C. M., Dodson W. C., Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab: 2005; 90 5 2571 2579 (Pubitemid 40686293)
13. Goodarzi M. O., Quiñones M. J., Azziz R., Rotter J. I., Hsueh W. A., Yang H. Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril: 2005; 84 3 766 769 (Pubitemid 41317746)
14. Moran C., Tena G., Moran S., Ruiz P., Reyna R., Duque X. Prevalence of polycystic ovary syndrome and related disorders in Mexican women. Gynecol Obstet Invest: 2010; 69 4 274 280
15. Lo J. C., Feigenbaum S. L., Yang J., Pressman A. R., Selby J. V., Go A. S. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab: 2006; 91 4 1357 1363
16. Coney P., Ladson G., Sweet S., Legro R. S. Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African-American women? Semin Reprod Med: 2008; 26 1 35 38
17. Nidhi R., Padmalatha V., Nagarathna R., Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol: 2011; 24 4 223 227
18. Chen X., Yang D., Mo Y., Li L., Chen Y., Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol: 2008; 139 1 59 64
19. Kumarapeli V., Seneviratne Rde A., Wijeyaratne C. N., Yapa R. M., Dodampahala S. H. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol: 2008; 168 3 321 328 (Pubitemid 352019785)
20. Kalra P., Bansal B., Nag P., et al. Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome. Fertil Steril: 2009; 91 (4, Suppl): 1437 1440
21. Wijeyaratne C. N., Seneviratne Rde A., Dahanayake S., et al. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Hum Reprod: 2011; 26 1 202 213
22. Yu Ng E. H., Ho P. C. Polycystic ovary syndrome in Asian women. Semin Reprod Med: 2008; 26 1 14 21
23. Li L., Yang D., Chen X., Chen Y., Feng S., Wang L. Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet: 2007; 97 2 129 134 (Pubitemid 46589453)
24. Nestler J. E., Jakubowicz D. J. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med: 1996; 335 9 617 623 (Pubitemid 26277951)
25. Nestler J. E., Jakubowicz D. J., Evans W. S., Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med: 1998; 338 26 1876 1880 (Pubitemid 28287859)
26. Lord J. M., Flight I. H., Norman R. J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ: 2003; 327 7421 951 953
27. Legro R. S., Barnhart H. X., Schlaff W. D., et al. Cooperative Multicenter Reproductive Medicine Network Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med: 2007; 356 6 551 566 (Pubitemid 46220816)
28. Seifer D. B., Frazier L. M., Grainger D. A. Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertil Steril: 2008; 90 5 1701 1710
29. Wellons M. F., Fujimoto V. Y., Baker V. L., et al. Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes. Fertil Steril: 2012; 98 2 406 409
30. Baker V. L., Luke B., Brown M. B., et al. Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril: 2010; 94 4 1410 1416
31. DeUgarte C. M., Bartolucci A. A., Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril: 2005; 83 5 1454 1460 (Pubitemid 40615820)
32. Mathur R., Alexander C. J., Yano J., Trivax B., Azziz R. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol: 2008; 199 6 596 609
33. Knowler W. C., Barrett-Connor E., Fowler S. E., et al. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med: 2002; 346 6 393 403 (Pubitemid 34437694)
34. Marshall J. C., Dunaif A. Should all women with PCOS be treated for insulin resistance? Fertil Steril: 2012; 97 1 18 22